VialsRx
“your prescription may be fulfilled by one of the following pharmacy partners: VialsRx 16402 FM 2920, Building D Tomball, TX 77377 Phone: 346-781-8772”
NativeMed Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: compounded semaglutide at one price for every dose
6.9
★★★☆☆6.9/10
NativeMed falls below our bar on oversight: the FDA has issued it a warning letter. Its compounded semaglutide costs $179 a month, 10% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
$159first month
then $179/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at NativeMed →
Compare top-rated alternatives ↓Prices checked October 2026
NativeMed, LLC is a Miami-based cash-pay telehealth seller. Month to month, compounded semaglutide costs $179 ($159 the first month) and tirzepatide $259 ($199 first month); its advertised $149 and $183 are 3-month plans paid up front. Prices are the same at every dose, shipping is free, and VialsRx of Tomball, TX, fills orders. The FDA sent NativeMed a warning letter on 06/08/2026 over its telehealth marketing.
By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $179/moPrice shown up frontFlat across dosesPharmacy named
Is NativeMed legit?
NativeMed is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate NativeMed 6.9/10 overall.
Is there a NativeMed promo or coupon code?
NativeMed has no code to type in. The current offer: Summer sale: compounded Semaglutide $149/month (reg $299, ~50% off), compounded Tirzepatide $183/month (reg $399, ~54% off), NAD+ $159/month (reg $199, 20% off); free initial consultation. It applies at checkout on its own. Coupon sites advertising a "NativeMed promo code" are not a source we can vouch for.
See how NativeMed compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to NativeMed
9.1/ 10
Verified partnerCollective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
★★★★★9.1/10
Editorial score · methodology
$59/mo+ membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →9.3/ 10
Verified partnerEmbody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
★★★★★9.3/10
Editorial score · methodology
$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →7.9/ 10
Verified partnerLuvo Health
Best for: moving between compounded and brand without changing seller
★★★★☆7.9/10
Editorial score · methodology
$179/mo
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Luvo Health review →NativeMed at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Shipping
- FDA status
- 1 FDA warning letter (details below)
How NativeMed scores
Six columns, each one computed from something NativeMed has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.8/10$179/month is 10% below the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.0/10The FDA has issued it a warning letter. It names the pharmacy that fills its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
4.5/10The price covers the medication and shipping.
6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on NativeMed
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Recorded which pharmacies the seller names as filling its prescriptions, with the page and date
- Checked FDA warning letters for NativeMed
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with NativeMed involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1NativeMed shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2VialsRx fills the prescriptions, and NativeMed names it publicly, which most sellers do not.
- 3The monthly price includes the medication and shipping.
Price shown before you start
- Lowest ongoing monthly price: semaglutide $179, tirzepatide $259. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that NativeMed serves your state before you start.
- The FDA has issued NativeMed a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting NativeMed
- Phone
- 855-850-8585
Cancelling NativeMed
Taken from the terms NativeMed publishes. Terms change, so check the current policy before you subscribe.
- Minimum commitment
- No minimum when paying monthly; a quarter at a time is charged in advance
- Refund policy
- Payments are non-refundable. A refund can be requested within 24 hours of purchase, before medication ships, minus a cancellation fee.
Medications NativeMed lists
NativeMed lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides NativeMed offers
NativeMed sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Injection, monthly plan, regular rate (opening month discounted)Compounded
$179$159/mo
Save 11% right nowsemaglutide
Monthly: '$179 per month', 'first month $159'. 3-month plan: $149/mo, '$447 paid upfront'. Same price at any dose; free shipping.
Injection, monthly plan, regular rate (opening month discounted)Compounded
$259$199/mo
Save 23% right nowtirzepatide
Monthly: '$259 per month', 'first month $199'. 3-month plan: $183/mo, '$549 paid upfront'.
Check the price yourself before you pay
Every figure here comes from NativeMed's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
NativeMed compounding-pharmacy partners
NativeMed names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
In its favor
- Semaglutide costs $179 a month, 10% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $259 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication and shipping
- Names VialsRx as the pharmacy that fills its prescriptions, which most sellers do not
Against it
- Confirm it serves your state before you start the intake
- The FDA has issued NativeMed a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What NativeMed charges
NativeMed advertises $159. That buys the first month. The standing rate is $179/month, and that is the one worth doing the math on, because the introductory figure applies once.
- Compounded semaglutide: $159 first month, then $179/month
- Compounded tirzepatide: $199 first month, then $259/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so NativeMed's $179 is genuinely below the middle, not just advertised that way. Before you pay, compare NativeMed's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Bodybuilding Health+, at about $179/month, is the closest like-for-like alternative we review.
What NativeMed dispenses
NativeMed prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
NativeMed tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. The FDA has issued NativeMed a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
NativeMed also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether NativeMed bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you want a cheap way to find out whether the medication suits you before committing
Our read
NativeMed is a cheap way to start and an ordinary way to continue. Use the $159 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $179/month before you let it renew twice. The catch is disclosure, which is why NativeMed scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
NativeMed falls below our bar on oversight: the FDA has issued it a warning letter. Its compounded semaglutide costs $179 a month, 10% below the $199 median among the sellers we compare.
Score: 6.9/10Best for: compounded semaglutide at one price for every doseFrom: $179/mo
Before you pay NativeMed
Starting at $179 a month. Check today's price, then start the intake.
Where NativeMed is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to NativeMed sets more sellers in the same category beside NativeMed on price, states and what the price includes.
Frequently Asked Questions
NativeMed, LLC is a Miami-based cash-pay telehealth seller. Month to month, compounded semaglutide costs $179 ($159 the first month) and tirzepatide $259 ($199 first month); its advertised $149 and $183 are 3-month plans paid up front. Prices are the same at every dose, shipping is free, and VialsRx of Tomball, TX, fills orders. The FDA sent NativeMed a warning letter on 06/08/2026 over its telehealth marketing. We rate it 6.9/10 overall.
The standing rate at NativeMed is $179 a month. The $159 figure is a first month, not what you pay from month two. Cost also moves with the medication and the dose, so read the row in the pricing table above that matches yours.
Ask NativeMed whether it serves your state before you start the intake, and get the answer in writing.
NativeMed lists compounded semaglutide and compounded tirzepatide.
NativeMed lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether NativeMed bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
NativeMed says the price covers medication and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. New patients are currently quoted $159 for the first month. NativeMed runs that whole sequence on its own site.
The FDA warning letter is the one that matters, and it is summarized at the top of this review. Also weigh these before you buy: Confirm it serves your state before you start the intake. Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Other sellers we cover include Gala, Luvo Health, and Bodybuilding Health+. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.
How to check NativeMed yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
NativeMed has an FDA warning letter on record, dated June 8, 2026
This letter concerns false & misleading claims/misbranded (telehealth). A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this NativeMed review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See NativeMed's current pricing
Plans start at $159 a month. Whether you qualify is a clinician's decision, made after your intake.
Not sold on NativeMed?
Vetted alternatives